Patents by Inventor Mathieu SCHMITT

Mathieu SCHMITT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230320979
    Abstract: An oil-in-water emulsion for intravitreal administration, especially injection, including an active ingredient, an oil, a mixture of two non-ionic surfactants and water, the emulsion having a droplet size ranging from about 100 to about 200 nm. The emulsion avoids troubles of vision after administration into the vitreous body. The emulsion provides good therapeutic activity of the active ingredient for treating eye diseases or conditions, such as an eye disease or condition of the posterior segment of the eye.
    Type: Application
    Filed: September 15, 2021
    Publication date: October 12, 2023
    Applicant: SANTEN SAS
    Inventors: Mathieu SCHMITT, Philippe DAULL, Jean-Sébastien GARRIGUE
  • Patent number: 11730732
    Abstract: A pharmaceutical liquid suspension comprising: temozolomide or a salt thereof; at least one agent controlling the solid state of temozolomide in suspension; a pharmaceutically acceptable liquid vehicle; and optionally at least one acid in a quantity so that the pH of the composition is below 5; or a powder blend for reconstituting said suspension, is provided.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: August 22, 2023
    Assignees: Orphelia Pharma, Institut Gustave Roussy
    Inventors: Maxime Annereau, Jérémy Bastid, Hugues Bienayme, François Lemare, Mathieu Schmitt, Lionel Tortolano, Samuel Abbou
  • Patent number: 10880153
    Abstract: Methods of and systems provide service redundancy between a master server and a slave server. The master server provides access to a pool of resources to a client. In response to detecting a fault on the master server, the master server is marked as disabled and services held on the master server are switched to the slave server and to a secondary pool of resources. The master service may be restarted if down. Then, provided that the master server is up, one or more tests are performed on the master server. The master server is marked as enabled if the tests are successful. The services may be switched back to the master server when the server is enabled. Services may further be rolled back to the slave server in case of an additional fault occurrence. The technique may also be used for updating a configuration in a service infrastructure.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: December 29, 2020
    Assignee: OVH
    Inventor: Mathieu Schmitt
  • Publication number: 20200188390
    Abstract: The present invention concerns a pharmaceutical composition, advantageously a liquid suspension, comprising: a. temozolomide or a salt thereof; b. at least one agent controlling the solid state of temozolomide in suspension; c. a pharmaceutically acceptable liquid vehicle, advantageously water; d. optionally at least one acid in a quantity so that the pH of the composition is below 5; or a powder blend for reconstituting said suspension.
    Type: Application
    Filed: December 13, 2019
    Publication date: June 18, 2020
    Applicants: Orphelia Pharma, Institut Gustave Roussy
    Inventors: Maxime ANNEREAU, Jérémy BASTID, Hugues BIENAYME, François LEMARE, Mathieu SCHMITT, Lionel TORTOLANO
  • Publication number: 20200067761
    Abstract: Methods of and systems provide service redundancy between a master server and a slave server. The master server provides access to a pool of resources to a client. In response to detecting a fault on the master server, the master server is marked as disabled and services held on the master server are switched to the slave server and to a secondary pool of resources. The master service may be restarted if down. Then, provided that the master server is up, one or more tests are performed on the master server. The master server is marked as enabled if the tests are successful. The services may be switched back to the master server when the server is enabled. Services may further be rolled back to the slave server in case of an additional fault occurrence. The technique may also be used for updating a configuration in a service infrastructure.
    Type: Application
    Filed: August 16, 2019
    Publication date: February 27, 2020
    Inventor: Mathieu SCHMITT
  • Publication number: 20180015166
    Abstract: Disclosed is a composition for use for topical administration onto the upper and/or lower eyelid of a subject. The composition includes a polyaphron, and the polyaphron includes: at least one hydrophilic phase; at least one hydrophobic phase; and at least one surfactant selected from ionic surfactants and/or non-ionic surfactants.
    Type: Application
    Filed: February 2, 2016
    Publication date: January 18, 2018
    Inventors: Mathieu SCHMITT, Kazutaka KIDO, Koji INAGAKI, Adeline BOUTTAZ